These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18437077)

  • 1. Proteomics of pancreatic cancer.
    Gräntzdörffer I; Carl-McGrath S; Ebert MP; Röcken C
    Pancreas; 2008 May; 36(4):329-36. PubMed ID: 18437077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomic analysis of human pancreatic juice: methodological study.
    Zhou L; Lu Z; Yang A; Deng R; Mai C; Sang X; Faber KN; Lu X
    Proteomics; 2007 Apr; 7(8):1345-55. PubMed ID: 17443640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic technologies and their application to pancreatic cancer.
    Vimalachandran D; Costello E
    Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical cancer proteomics: promises and pitfalls.
    Alaiya A; Al-Mohanna M; Linder S
    J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proteomic analysis of pancreatic cancer by 2-dimensional gel electrophoresis.
    Deng R; Lu Z; Chen Y; Zhou L; Lu X
    Pancreas; 2007 Apr; 34(3):310-7. PubMed ID: 17414053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomic profiling of pancreatic cancer juice.
    Chen R; Pan S; Yi EC; Donohoe S; Bronner MP; Potter JD; Goodlett DR; Aebersold R; Brentnall TA
    Proteomics; 2006 Jul; 6(13):3871-9. PubMed ID: 16739137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of solid and cystic lesions of the pancreas.
    Khalid A; Finkelstein S; McGrath K
    Clin Lab Med; 2005 Mar; 25(1):101-16. PubMed ID: 15749234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome informatics for cancer research: from molecules to clinic.
    Brusic V; Marina O; Wu CJ; Reinherz EL
    Proteomics; 2007 Mar; 7(6):976-91. PubMed ID: 17370257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers.
    Gortzak-Uzan L; Ignatchenko A; Evangelou AI; Agochiya M; Brown KA; St Onge P; Kireeva I; Schmitt-Ulms G; Brown TJ; Murphy J; Rosen B; Shaw P; Jurisica I; Kislinger T
    J Proteome Res; 2008 Jan; 7(1):339-51. PubMed ID: 18076136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer.
    Hibi T; Mori T; Fukuma M; Yamazaki K; Hashiguchi A; Yamada T; Tanabe M; Aiura K; Kawakami T; Ogiwara A; Kosuge T; Kitajima M; Kitagawa Y; Sakamoto M
    Clin Cancer Res; 2009 Apr; 15(8):2864-71. PubMed ID: 19351749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases.
    Zhao H; Adler KB; Bai C; Tang F; Wang X
    J Proteome Res; 2006 Apr; 5(4):743-55. PubMed ID: 16602680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance proteomics as a tool in biomarker discovery.
    Meyer HE; Stühler K
    Proteomics; 2007 Sep; 7 Suppl 1():18-26. PubMed ID: 17893859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer: proteomic approaches to a challenging disease.
    Tonack S; Aspinall-O'Dea M; Neoptolemos JP; Costello E
    Pancreatology; 2009; 9(5):567-76. PubMed ID: 19657212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
    Farina A; Dumonceau JM; Frossard JL; Hadengue A; Hochstrasser DF; Lescuyer P
    J Proteome Res; 2009 Jan; 8(1):159-69. PubMed ID: 19055478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S; Hongsachart P; Sriyam S; Tantipaiboonwong P; Phutrakul S; Chen ST
    Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.